Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Propofol Induced Pain
NCT00146926Phase 3Unknown
- Sponsor
- Hospices Civils de Lyon
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine, ephedrine and lidocaine, sponsored by Hospices Civils de Lyon. Primary endpoint: Propofol-induced pain score. Status: unknown.
02
Drugs
ketamineephedrinelidocaine
Beyond the preview
Go deeper on NCT00146926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146926.